Translational News and Research RSS Feed - Translational News and Research

Einstein, Montefiore receive grant to establish home health services for people with IDD

Einstein, Montefiore receive grant to establish home health services for people with IDD

Albert Einstein College of Medicine of Yeshiva University and Montefiore Medical Center in collaboration with Developmental Disabilities Health Alliance of New York and Community Resource Center for the Developmentally Disabled, Inc., have received a $2.4 million grant to integrate medical and mental healthcare for children and adults with intellectual and developmental disabilities (IDD). [More]
Marital hostility, history of depression can increase obesity risk in adults

Marital hostility, history of depression can increase obesity risk in adults

The double-whammy of marital hostility and a history of depression can increase the risk for obesity in adults by altering how the body processes high-fat foods, according to new research. [More]
Study reveals that people with stress-related inflammation may suffer from depression

Study reveals that people with stress-related inflammation may suffer from depression

Preexisting differences in the sensitivity of a key part of each individual's immune system to stress confer a greater risk of developing stress-related depression or anxiety, according to a study conducted at the Icahn School of Medicine at Mount Sinai and published October 20 in the Proceedings of the National Academy of Sciences. [More]
UNMC researcher receives $3.3 million grant to study rare diseases that affect children

UNMC researcher receives $3.3 million grant to study rare diseases that affect children

University of Nebraska Medical Center researcher, William Rizzo, M.D., has received a five-year, $3.3 million grant to study 10 rare diseases that affect children beginning in infancy or early childhood and throughout their life. [More]
Van Andel Research Institute commits $7.5M to support epigenetic therapy in cancer treatment

Van Andel Research Institute commits $7.5M to support epigenetic therapy in cancer treatment

The work of one of the Stand Up To Cancer (SU2C) inaugural Dream Teams, launched in 2009 to focus on epigenetic therapy in cancer treatment, will continue with the commitment of $7.5 million from Van Andel Research Institute (VARI). [More]
Directed Genomics, New England Biolabs to develop new technologies for NGS

Directed Genomics, New England Biolabs to develop new technologies for NGS

New England Biolabs (NEB®) and Directed Genomics together announce that they have established a partnership to develop a suite of new technologies for next generation sequencing (NGS), including target enrichment. [More]
Researchers receive NIH grant to study mechanisms of auditory hypersensitivity in fragile X syndrome

Researchers receive NIH grant to study mechanisms of auditory hypersensitivity in fragile X syndrome

Fragile X syndrome (FXS) is a genetic disorder in humans that causes social impairments and repetitive behaviors, and other behaviors on the autistic spectrum, as well as cognitive deficits. [More]
NIAID announces license agreement to develop dual-purpose candidate vaccines for rabies, Ebola

NIAID announces license agreement to develop dual-purpose candidate vaccines for rabies, Ebola

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, today announced a new license agreement aimed at advancing dual-purpose candidate vaccines to protect against rabies and Ebola viruses. [More]
SOFIE BIOSCIENCES awarded NCI Phase II SBIR contract to develop [18F]FAC PET

SOFIE BIOSCIENCES awarded NCI Phase II SBIR contract to develop [18F]FAC PET

SOFIE BIOSCIENCES, a leader in the field of Positron Emission Tomography (PET) imaging, including probes, scanners, and chemistry systems, announced today that the National Cancer Institute has awarded the company a Phase II Small Business Innovation Research (SBIR) contract for approximately $1.5M over two years. [More]
Sheffield researchers find vital new evidence on how to reverse effects of Parkinson's mutation

Sheffield researchers find vital new evidence on how to reverse effects of Parkinson's mutation

Researchers from the University of Sheffield have found vital new evidence on how to target and reverse the effects caused by one of the most common genetic causes of Parkinson's. [More]
Addressing the evolution of diversity in medical education

Addressing the evolution of diversity in medical education

A perspective piece in this week's issue of the New England Journal of Medicine from a student at the University of Pennsylvania's Perelman School of Medicine addresses the evolution of diversity in medical education. [More]
Penn Medicine announces recipients of new Basser External Research Grant Program

Penn Medicine announces recipients of new Basser External Research Grant Program

The University of Pennsylvania's Basser Research Center for BRCA has announced $6.9 million to research teams both at Penn and at five other institutions across the United States, aimed at advancing the care of patients living with BRCA1 and BRCA2 mutations through multi-disciplinary collaboration. [More]
NYSCF names six promising scientists as 2014 NYSCF – Robertson Investigators

NYSCF names six promising scientists as 2014 NYSCF – Robertson Investigators

The New York Stem Cell Foundation today named six of the most promising scientists as its 2014 NYSCF – Robertson Investigators. [More]
UMMS, UMMSM researchers identify key genetic pathway underlying bipolar disorder

UMMS, UMMSM researchers identify key genetic pathway underlying bipolar disorder

A team of scientists led by researchers at the University of Massachusetts Medical School and the University of Miami Miller School of Medicine have identified what is likely a key genetic pathway underlying bipolar (manic depressive) disorder, a breakthrough that could lead to better drugs for treating bipolar affective disorder, as well as depression and other related mood disorders. [More]

Rare Diseases Clinical Research Network awarded $29 million NIH grant

The National Institutes of Health has awarded $29 million to the Rare Diseases Clinical Research Network, which is dedicated to furthering translational research and investigating new treatments for patients with rare diseases. [More]
Researchers develop DNA-based drug delivery system that targets cancer cells

Researchers develop DNA-based drug delivery system that targets cancer cells

Biomedical engineering researchers have developed a drug delivery system consisting of nanoscale "cocoons" made of DNA that target cancer cells and trick the cells into absorbing the cocoon before unleashing anticancer drugs. The work was done by researchers at North Carolina State University and the University of North Carolina at Chapel Hill. [More]
Penn State scientists find that mitochondrial disease more prevalent in older moms

Penn State scientists find that mitochondrial disease more prevalent in older moms

The discovery of a "maternal age effect" by a team of Penn State scientists that could be used to predict the accumulation of mitochondrial DNA mutations in maternal egg cells -- and the transmission of these mutations to children -- could provide valuable insights for genetic counseling. [More]
Four UCLA researchers receive NIH Director's New Innovator Award

Four UCLA researchers receive NIH Director's New Innovator Award

Four scientists from the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have received a National Institutes of Health Director's New Innovator Award that will forward revolutionary stem cell and neuro-science in medicine. [More]
Penn prediction tool increases sepsis identification and care, indicates fewer deaths

Penn prediction tool increases sepsis identification and care, indicates fewer deaths

An automated early warning and response system for sepsis developed by Penn Medicine experts has resulted in a marked increase in sepsis identification and care, transfer to the ICU, and an indication of fewer deaths due to sepsis. A study assessing the tool is published online in the Journal of Hospital Medicine. [More]

Economic cost of adolescent chronic pain is $19.5 billion a year

Research in The Journal of Pain estimated that the economic cost of moderate to severe chronic pain in adolescents is $19.5 billion a year. The Journal of Pain is the peer-reviewed publication of the American Pain Society. [More]